Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2307.07040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Dung T Huynh und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungnam National University, Daejeon 34314, Republic of Korea. Hauptthemen laut MEDLINE: Lacticaseibacillus casei, Influenza A Virus, H5N2 Subtype, Influenza A virus, Influenza Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chungnam National University.
Abstract (Originalsprache)
Avian influenza is a serious threat to both public health and the poultry industry worldwide. This respiratory virus can be combated by eliciting robust immune responses at the site of infection through mucosal immunization. Recombinant probiotics, specifically lactic acid bacteria, are safe and effective carriers for mucosal vaccines. In this study, we engineered recombinant fusion protein by fusing the hemagglutinin 1 (HA1) subunit of the A/Aquatic bird/Korea/W81/2005 (H5N2) with the Bacillus subtilis poly γ-glutamic acid synthetase A (pgsA) at the surface of Lactobacillus casei (pgsA-HA1/L. casei). Using subcellular fractionation and flow cytometry we confirmed the surface localization of this fusion protein. Mucosal administration of pgsA-HA1/L. casei in mice resulted in significant levels of HA1-specific serum IgG, mucosal IgA and neutralizing antibodies against the H5N2 virus. Additionally, pgsA-HA1/L. casei-induced systemic and local cell-mediated immune responses specific to HA1, as evidenced by an increased number of IFN-γ and IL-4 secreting cells in the spleens and higher levels of IL-4 in the local lymphocyte supernatants. Finally, mice inoculated with pgsA-HA1/L. casei were protected against a 10LD50 dose of the homologous mouse-adapted H5N2 virus. These results suggest that mucosal immunization with L. casei displaying HA1 on its surface could be a potential strategy for developing a mucosal vaccine against other H5 subtype viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Chungnam National University, Daejeon 34314, Republic of Korea.
Förderung
- Chungnam National University
Zitieren
APA
Huynh, D. T., Chathuranga, W. A. G., Chathuranga, K., Lee, J. S., & Kim, C. J. (2024). Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2307.07040
Vancouver
Huynh DT, Chathuranga WAG, Chathuranga K, Lee JS, Kim CJ. Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2307.07040
BibTeX
@article{Huynh2024,
author = {Huynh, Dung T and Chathuranga, W A Gayan and Chathuranga, Kiramage and Lee, Jong-Soo and Kim, Chul-Joong},
title = {Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2307.07040}
}
EUVIMED